A novel method for rapid molecular subgrouping of medulloblastoma.
| Author | |
|---|---|
| Abstract | :
The classification of medulloblastoma into WNT, SHH, Group 3 and Group 4 subgroups has become of critical importance for patient risk-stratification and subgroup-tailored clinical trials. Here, we aimed to develop a simplified, clinically applicable classification approach that can be implemented in the majority of centers treating patients with medulloblastoma. |
| Year of Publication | :
2018
|
| Journal | :
Clinical cancer research : an official journal of the American Association for Cancer Research
|
| Date Published | :
2018
|
| ISSN Number | :
1078-0432
|
| URL | :
http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=29351917
|
| DOI | :
10.1158/1078-0432.CCR-17-2243
|
| Short Title | :
Clin Cancer Res
|
| Download citation |